Do prophylactic anticonvulsants in patients with brain tumors decrease the incidence of seizures?

Wisconsin Medical Journal

Volumn 104, Issue 6, 2005, Pages 9-10

  Wassenaar, Tim ^a   Feldstein, David ^a,b  

^a University of Wisconsin Health   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; PHENYTOIN;

ARTICLE; BRAIN TUMOR; CANCER SURGERY; CLINICAL FEATURE; DRUG ERUPTION; HEMATOLOGIC DISEASE; HUMAN; NEUROLOGIC EXAMINATION; NEUROSURGERY; SEIZURE; STEVENS JOHNSON SYNDROME; CASE REPORT; INCIDENCE; MALE; MIDDLE AGED;

ANTICONVULSANTS; BRAIN NEOPLASMS; HUMANS; INCIDENCE; MALE; MIDDLE AGED; SEIZURES;

EID: 27744575763     PISSN: 10981861     EISSN: 10981861     Source Type: Journal    
DOI: None     Document Type: Article

References (2)

1. Sirven J, Wingerchuk D, Drazkowski J, Lyons M, Zimmerman R. Seizure prophylaxis in patients with brain tumors: a meta-analysis. Mayo Clinic Proc. 2004;79(12):1489-1494.
2. Sackett DL. Evidence-Based Medicine: How to Practice and Teach EBM. 2nd ed. Churchill Livingstone; 2000.